Short-term clinical outcomes showed non-inferiority between a regimen combining a direct oral anticoagulant with a beta-blocker and a regimen combining a direct oral anticoagulant with a class III antiarrhythmic in patients diagnosed with atrial fibrillation, according to a prospective observational study published in BMC Cardiovascular Disorders.
Atrial fibrillation frequently occurs alongside structural cardiac remodeling as well as multiple concurrent health conditions. To examine these associations, researchers designed the prospective observational investigation to characterize the demographic, echocardiographic, and biological profiles of affected individuals and to evaluate how different therapeutic protocols performed over a short follow-up window.
The study enrolled 81 patients with atrial fibrillation who underwent detailed baseline evaluations, including comprehensive echocardiography alongside biochemical and hormonal analyses. Patients were randomized to two treatment protocols, with investigators tracking time-to-event outcomes at three-month and six-month follow-up visits using Cox proportional hazards regression models with a significance threshold established at a p value of less than 0.05.
The patient cohort had an average age of 64.4 ± 11.0 years, with 51.6 percent of the participants aged 65 years or older. A majority of the enrolled individuals were male, reflecting the demographic distribution within the evaluated clinical cohort.
Echocardiographic measurements demonstrated an average left ventricular ejection fraction of 55.3 percent across the study population. Evidence of structural cardiac remodeling was widespread, marked by left atrial enlargement in 81.1 percent of patients, left ventricular hypertrophy in 53.7 percent, left ventricular dilation in 49.5 percent, right atrial enlargement in 48.4 percent, and right ventricular dilation in 46.3 percent.
Biochemical and clinical testing revealed a notable burden of concurrent systemic conditions among the participants. Heart failure was documented in 46.3 percent of the cohort, predominantly presenting as heart failure with preserved ejection fraction, while hepatocytolysis was detected in 48.4 percent, thyroid disorders were observed in 17.9 percent, and renal impairment affected 15.8 percent of the patients.
Direct comparisons between the two treatment arms revealed largely comparable echocardiographic and biological parameters, although patients assigned to direct oral anticoagulants plus beta-blockers exhibited a significantly higher left atrial volume than those receiving class III antiarrhythmics (p = 0.045). Both therapeutic strategies proved generally well tolerated, with the demonstrated non-inferiority in short-term outcomes supporting the implementation of rate-control approaches in appropriately selected patients.
Published as an open-access research paper on November 3, 2026, the report represents peer-reviewed accepted findings shared ahead of the final Version of Record to facilitate early access to clinical outcome data.
Subject of Research: Short-term clinical outcomes and patient characteristics across atrial fibrillation treatment regimens
Article Title: Clinical, echocardiographic and biological characteristics and short-term outcomes of patients with atrial fibrillation according to treatment regimen: a prospective observational study
Article References: Lubenga, Y. N., Nkodila, A. N., Otshudi, R. K., Masendu, D. M., Tshilanda, M. B., Kabamba, R. K., Kadima, C. N., Zokere, T. B., Pambu, D., Gondele, D. I., Irung, O. I., Kintoki, E. V., Mbutiwi, F. I. N., Buila, N. B., & M’buyamba-Kabangu, J.-R. (2026). Clinical, echocardiographic and biological characteristics and short-term outcomes of patients with atrial fibrillation according to treatment regimen: a prospective observational study. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-06963-7
Image Credits: AI Generated
DOI: 10.1186/s12872-026-06963-7
Keywords: atrial fibrillation, cardiac remodeling, direct oral anticoagulants, beta-blockers, class III antiarrhythmics, echocardiography, left ventricular ejection fraction, left atrial enlargement, left ventricular hypertrophy, right ventricular dilation, right atrial enlargement, heart failure with preserved ejection fraction, renal impairment, hepatocytolysis, thyroid disorders, rate control, Cox proportional hazards, prospective observational study
News Source: Ophelia Keating. (November 10, 2026). Atrial Fibrillation Regimens Yield Comparable Short-Term Outcomes in Prospective Study. Scienmag.



